exRNAdisease

Entry Detail

---



General Information

Database ID: exR0728555 RNA Name: hsa-miR-1294 RNA Type: miRNA Chromosome: chr5 Starnd: + Coordinate: Start Site(bp): 154347153 End Site(bp): 154347174 External Links: hsa-miR-1294

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Advanced Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand CYB5R3 chr22 42617840 42649392 - STK40 chr1 36339624 36385896 - EIF4A1 chr17 7572706 7579006 + TRAPPC10 chr21 44012309 44106552 + ABCA1 chr9 104781006 104928155 - POGK chr1 166839447 166856344 + FGFR1 chr8 38400215 38468834 - KMT2A chr11 118436490 118526832 + RAB8A chr19 16111889 16134234 + TEX261 chr2 70985942 70994873 - ANKRD49 chr11 94493979 94499578 + PGRMC1 chrX 119236245 119244466 + PTMS chr12 6765516 6770952 + CRY2 chr11 45847118 45883248 + PTP4A1 chr6 63521746 63583436 + APLP2 chr11 130068147 130144811 + CDKN1B chr12 12715058 12722369 + UBE2G2 chr21 44768580 44801826 - PDPR chr16 70113626 70162537 + AKT2 chr19 40230317 40285536 - RNF157 chr17 76142465 76240493 - ZHX3 chr20 41178448 41317672 - ARHGAP28 chr18 6729718 6915716 + PRRC2B chr9 131373636 131500197 + FYCO1 chr3 45917899 45995824 - ZNF512B chr20 63956704 63969930 - SMAD7 chr18 48919853 48952052 - PDE4DIP chr1 148808181 149048286 + TAGLN2 chr1 159918107 159925732 - NACC1 chr19 13116862 13141147 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000247 chr10 74474868 74475660 + hsa_circ_0000798 chr17 65941524 65944422 + hsa_circ_0000246 chr10 74468040 74475660 + hsa_circ_0001085 chr2 191765289 191789319 + hsa_circ_0000744 chr17 15968183 15971435 - hsa_circ_0000799 chr17 65941524 65972074 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC007161.3 chr7 7640752 8004053 + AC021078.1 chr5 149494314 149504670 - AC022150.4 chr19 52650437 52653284 - AL022311.1 chr22 37876148 37895563 + H19 chr11 1995176 2001470 - LINC00265 chr7 39733430 39793092 + NEAT1 chr11 65422774 65445540 + TUG1 chr22 30969245 30979395 + Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA